Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase 1 4Phase 4 1Phase 2 1

Status

Completed 4

Sponsor Class

INDUSTRY 778OTHER 595NIH 116NETWORK 13OTHER_GOV 4FED 4UNKNOWN 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4Breast 4Gastrointestinal 3Gynecologic 2Genitourinary 2CNS 2Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Breast Neoplasms 4Ovarian Neoplasms 2Stroke 1Diabetes Mellitus 1Coronary Disease 1Colorectal Neoplasms 1Breast Neoplasms, Male 1

Interventions

sargramostim 1Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × FED × Breast × Clear all
NCT00841399 2020-03-31

Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients

Walter Reed Army Medical Center

Phase 1 Completed
100 enrolled
Breast

Breast Neoplasms

NCT00854789 2020-03-31

Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer

Walter Reed Army Medical Center

Phase 1 Completed
95 enrolled
Breast

Breast Neoplasms

NCT02019524 2020-03-18

J65

San Antonio Military Medical Center

Phase 1 Completed
39 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Breast Neoplasms, Male

NCT00164658 2010-01-07

Evaluating Tools for Health Promotion and Disease Prevention

Centers for Disease Control and Prevention

Phase 1 Completed
8,400 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Coronary Disease, Diabetes Mellitus, Ovarian Neoplasms, Colorectal Neoplasms, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡